BioScience Health Innovations (BHIC) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access BHIC Annual Balance Sheets →
This page allows investors to track BioScience Health Innovations's balance sheet development across multiple reporting periods.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent0.71
Cash & Short-term Investments0.00
Accounts receivable0.40
Other Receivables0.00
Inventories0.80
Other Current Assets0.04
Total loans net0.04
Total Current Assets1.99
Intangible Assets0.11
Financial Instruments0.00
Tax Assets, Noncurrent0.03
Other Assets, Noncurrent0.00
Total Assets2.14
Liabilities
Accounts Payable0.01
Accrued Liabilities, Current0.03
Short-term Debt0.26
Taxes Payable0.00
Deferred Liability and Revenue0.00
Total Current Liabilities0.30
Total Long-term Debt0.00
Other liabilities, Noncurrent0.00
Total Liabilities0.30
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock1.95
Retained Earnings / Accumulated Deficit-0.11
Common Stockholder's Equity1.83
Preferred Stockholder's Equity0.00
Total Stockholder's Equity1.83
Liabilities & Stockholder's Equity2.14
4 historic quarters locked

Sign in to unlock the full BioScience Health Innovations balance sheet history.

About Bioscience Health Innovations Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001096906-26-001173

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.